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Background: Previous studies have demonstrated obesity to be paradoxically associated with lower mortality in patients with ST-Elevation 
Myocardial Infarction (STEMI), however the mechanism of this relationship remains unclear. We sought to evaluate whether time from symptom onset 
to reperfusion is a potential confounder of these outcomes.
methods: We performed a retrospective review of consecutive patients with STEMI who underwent primary percutaneous coronary intervention 
(PCI). We used multivariate linear regression to evaluate the relationship between obesity (body mass index [BMI] ≥ 30 Kg/m2) and time from 
symptom onset to reperfusion.
results: 413 patients with STEMI were analyzed. Mean age 62 years, 80% males, 51% smokers, 63% hypertensive, 30% diabetic, 58% dyslipidemic. 
27% of the study population was obese. There were no significant differences in the baseline characteristics analyzed between the obese and 
non-obese groups (Table). Although obese patients had smaller infarcts as assessed by total creatine kinase (CK), there was no difference in other 
measures of morbidity and mortality between groups. There was no significant difference in time to reperfusion between groups (mean 569.1 minute 
vs. 482.3 minute, p=0.5). Multivariate p-value = 0.2.
conclusions: We found that in STEMI patients undergoing primary PCI, body mass had no effect on time to reperfusion or other measures of 
morbidity or mortality. Enzymatic infarct size was smaller in obese patients. 
Grp(BMI <30) (N=303) Grp(BMI≥30) (N=110) P-value
Age (yrs)
Gender (M)
Smoker
HTN
DM
Dyslipidemia
Prior CAD
62.1
81.5% (247)
53.1% (161)
60.4% (183)
28.7% (87)
57.1% (173)
23.8% (72)
61.2
75.5% (83)
44.5% (49)
68.2% (75)
31.8% (35)
61.8% (68)
22.7% (25)
NS
Ethnicity
Asian
Black
White
Hispanic
28.7% (87)
4.3% (13)
53.8% (163)
13.2% (40)
30.0% (33)
3.6% (4)
54.5% (60)
11.8% (13)
NS
GFR<60mg/min/1.73 m2(MDRD)
Admission
Discharge
23.1% (70)
19.5% (59)
27.3% (30)
20.9% (23)
NS
Ischemic Time (Min)
≤180
569.1
36.6% (111)
482.3
42.7% (47)
NS
Infarct related artery
LAD
52.1% (158) 57.3% (63) NS
Angiographic LVEF≤50% 67.7% (205) 69.1% (76) NS
Improvement(LVEF≥50%) 49.5% (150) 46.4% (51) NS
Initial CK (IU/L)
Peak CK
All cause mortality
(In-hospital, 30 day and one year)
477.1
2712.1
5.9% (18)
422.4
1855.7
7.2% (8)
0.001
